Is there still a place for the mighty pharmaceutical sales force?
For the better part of the last decade, the diminishing role of the pharmaceutical sales representative as an integral part of the pharmaceutical sales model has been a hot topic. In the last six months, news of sales reps being banned from a large, acute-care hospital system made industry waves. A week later, pharma sales reps were under attack in Australia when a group of physicians banded together to start a “No Advertising Please” campaign designed to keep reps out. Read
Uplytic/HCP - the Science of Segmentation
The first on demand, data driven HCP segmentation engine built specifically for biopharma. #video #segmentation
Rep and a Hard Place
In April 1969 Medical Marketing & Media published the results of an exclusive Detailing & Physician Survey, from which its editors concluded the following: The role of the pharmaceutical “detailman” will remain relevant, despite analysts’ contentions that computer machines may someday replace systems of distribution and dissemination. Read . . .